## 



## 

## 

## 

|||Page No|
|---|---|---|
|Trustees'<br>Report<br>Introduction||1|
|Objectives and Activities<br>Achievements<br>and Performance||1-3<br>3-9|
|Financial<br>Review||9-10|
|Plans for the Future<br>Structure,<br>Governance<br>Statement of Trustees'|and Management<br>Responsibilities|11<br>11-14<br>15|
|Independent<br>Auditors'<br>Report||16-18|
|Statement of Financial Activities||19|
|Balance Sheet||20|
|Statement of Cashflaws||21|
|Notes to the Financial Statements||22-28|





## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

|Anatomical<br>Society|Natural<br>Environment<br>Research Council|Natural<br>Environment<br>Research Council|
|---|---|---|
|Animal<br>Free Research|The Nutrition|Society|
|Arts and Humanities<br>Research Council|Queen<br>Mary|University of London|
|Babraham<br>Institute|Royal Academy ofEngineering||
|Biotechnology<br>and Biological Sciences Research|Royal Society ofChemistry||
|Council|||
|Birkbeck, University<br>of London|Science and Technology<br>Facilities||
||Council||
|British Heart Foundation|Society for Chemical<br>Industry||
|Brunel University|Swansea<br>University||
|Ceramysis|University<br>College London||
|Durham<br>University|University<br>of|Birmingham|
|Economic and Social Research Council|University<br>of|Central Lancashire|
|Elizabeth<br>Blackwell institute for Health Research|University<br>of|East Anglia|
|Engineering<br>and Physical Sciences Research Council|University<br>of|Edinburgh|
|Genesis Research Trust|University<br>of|Huddersfield|
|Imperial<br>College London|University<br>of|Leeds|
|Institute ofCancer Research|University<br>of|Leicester|
|John Innes Centre|University<br>of|Liverpool|
|The Kennedy Trust|The University|ofManchester|
|Kidney Research<br>UK|The University|of Nottingham|
|Medica<br>I Resea rch Council|University<br>of|Strathclyde|
|Medical Resea rch Scotland|University<br>of|Surrey|
|National<br>Physical laboratory|University<br>of|York|





## 

## 

|r awarded<br>and waiting for lockdown<br>r|estrictions to ease before commencing<br>Fel|
|---|---|
|Alan Turing Institute|Royal Academy of Engineering|
|British Heart Foundation|Teesside University|
|Kidney Research<br>UK<br>Medical Research Council|The University of Nottingham<br>University of Roehampton|



|nnual or biennial<br>basis and the Trust is delighted to be wo|rking<br>with them. They are:||
|---|---|---|
|Alan Turing Institute<br>Biotechnology<br>and Biological Sciences Research Council<br>British Heart Foundation|Medical Research Scotland<br>Natural<br>Environment<br>Research <br>Royal Academy ofEngineering|Council|
|Durham<br>University<br>Economic and Social Research Council|Royal Society ofChemistry<br>Science<br>and<br>Technology|Facilities|
||Council||
|Engineering<br>and Physical Sciences Research Council<br>Imperial<br>College London<br>John Innes Centre|University ofLeicester<br>University of Nottingham<br>University<br>ofOxford||
|Kidney Research<br>UK<br>Medical Research Council|University ofSurrey<br>University<br>ofYork||



## 



## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 



## 

## 

## 



## 

## 



## 

## 



## 

## 

## 

## 



## 



|||||Ol <br>CIl <br>O|M<br> 00<br> IIl|C)<br>PV||I<br>Ol|Ol||||||LA||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||m <br>~ <br>0I-|'0<br> cw<br> CI.||Ill <br>CQ|(Il|OO<br>OO||O<br>O|O<br>O|||m||00<br>O|ID<br>LIl||
||||||||||||||||4-I||
||0|||ID<br>II1||||IDO|O|O<br>LIl|LIl<br>Ltl|Ol|||C4<br>Ol||
||IJ <br>z|'0<br> cw||pOl<br>rV||||LIl<br>Ol<br>ID|Ol|rVO|LDct<br>tel|LA<br>LIl(4|||clOO||
||IU|II|||||||||||||||
||QJ||||||||||||||||
||OC||||||||||||||||
||0<br>QI<br>O<br>+ <br>N|w'0<br> s w||Ill <br>W <br>cf' <br>00|rE<br> CQ<br> ttl|ID<br>LA<br>OO<br>ID<br>CT)||I<br>OO<br>00||Ol<br>(VO<br>Ill<br>CV||00<br>(V<br>LA<br>IV||O<br>00<br>Ol<br>CV|O<br>llI||
||QI<br>~|LL|||||||||||||||
||CD||||||||||||||||
|o<br>tV<br>Ct|IU W<br>+'rw<br>0I- II.|||W <br>O <br>OQ<br>Ol<br>Llj|Ol<br> Ill|ID<br>rV<br>OO<br>CB<br>Ill||O<br>C4<br>Ill<br>P7|O<br>(V<br>LA<br>ltl|ID<br>O<br>ct||IJlO<br>N||LA<br>&4<br>ID|COO<br>IIl<br>Ol<br>Ol||
|CCI|||||||||||||||||
|0z<br>XI-<br>CO<br>teal||||N<br>&V<br>CO<br>Ltl||OO<br>LA||I<br>OQ<br>O|00<br>(4<br>O||CO<br>Ill|O||CV<br>Ol<br>OO|ID||
|Q|||||||||||||||||
|CIZ|||||||||||||||||
|OC|'0|||IJI|Ol|||I||||||O|||
||QI|||CO <br>iV|LlI<br> H|||Ol||CQ<br>'IU'|(V<br>CO||||||
|ZI-|0cw<br>IA<br>QI II|||&4||||(Il||CV||||Ltl|||
|0|c<br>D||||||||||||||||
|||||||||||||||||IU|
|||||||||||||||||b0|
|||||||||||||||||0<br>O|
|||||||||||||||||E0|
|||||||||||||||||III—|
|||||||||||||||||QI|
|||||||||||||||"0||GJ|
||||ZO<br>O<br>Z|C0<br>QJ<br>IU<br>0C<br>CI<br>0 c<br>+<br>C C<br>m"<br>+J<br>Vi<br>m ~||0<br>IU0<br>I—|IU<br>Z.~ ~<br>0<br>lC<br>UJ 'g~<br>IU<br>I-<br>CI O.<br>+<br>IU<br>QIX<br>Z<br>W Z<br>QI<br>0<br>m M<br>X<br>0<br>w&O||QJ<br>'0<br>C<br>QJ<br>QJ<br>tU0I-|CI<br>0I:<br>CI0.<br>X<br>ID<br>IU<br>E0<br>C<br>Qiz|O<br>CI<br>QI<br>tLI<br>L<br>QI<br>C<br>IU<br>I—|0c<br>C<br>CI<br>E<br>CJ)0<br>E<br>OZ|OzD<br>0<br>Z0I-<br>Uz0<br>OC|IU<br>bO<br>0<br>II<br>IU<br>0|'II0<br>0<br>CI<br>IU\J<br>'Z$C<br>tU<br>0I-|QI<br>I<br>IU<br>QJ<br>CI<br>0<br>IU<br>QJ<br>II0|





|||BALANCE|SHEET AS AT 30TH NOVEMBER 2021|SHEET AS AT 30TH NOVEMBER 2021|||
|---|---|---|---|---|---|---|
|||||2021|2020||
||||Note||||
|FIXEDASSETS<br>Tangible assets|||10|1,757||2,105|
|CURRENT ASSETS<br>Debtors<br>Cash at hand and in|bank|||348,159<br>2,645,520|252,179<br>2,225,034||
|||||2,993,679|2,477,213||
|CURRENT LIABILITIES|||||||
|Creditors; Amounts<br>one year|falling|due within|12|1,296,128|1,023,066||
|Net current assets||||1,697,551||1,454,147|
|NET ASSETS||||E1,699,308||E1,456,252|
|THE FUNDS OF THE CHARITY|||||||
|Restricted funds|||16|1,111,637||1,004,922|
|Unrestricted<br>funds||||587,671||451,330|
|TOTAL CHARITY FUNDS|||16|E1,699,308||E1,456,252|





## 

## 

## 

||||||2021|2020|
|---|---|---|---|---|---|---|
|||||Notes|||
|CASH FLOWS FROM OPERATING|||||||
|ACTIVITIES|||||||
|Net cash used in/(provided<br>by) in|operating||||||
|activities|||||421,326|707,128|
|CASH FLOWS FROM INVESTING ACTIVITIES|||||||
|Bank Interest|||||159|3,381|
|Purchase ofTangible<br>Fixed Assets|||||(999)|(2,936)|
|Net cash provided<br>by investment|activities||||(840)|445|
|CHANGE<br>IN CASH AND CASH EQUIVALENTS|||||||
|IN THE FINANCIAL YEAR|||||420,486|707,573|
|Cash and Cash Equivalents<br>at the|beginning||||||
|ofthe financial year|||||2,225,034|1,517,461|
|Cash and Cash Equivalents<br>at the|end||||||
|ofthe financial year|||||E2,645,520|E2,225,034|
|NOTES TO THE STATEMENT OF|||||2021|2020|
|CASH FLOWS|||||E|E|
|A)<br>Reconciliation<br>of Net Expenditure|||to Net Cash Flow from||||
|Operating<br>Activities|||||||
|Net Income to Net Cash Flow|||||||
|From Operating<br>Activities|||||||
|Net Income for the Financial|Year||||243,056|377,473|
|Adjustments<br>for<br>—<br>Depreciation|||||1,347|1,031|
|Bank Interest received|||||(159)|(3,381)|
|increase||in|Debtors||(95,980)|(118,405)|
|increase||in|Creditors||273,062|450,410|
|Net cash used in/(provided<br>by) Operating||||Activities|f421,326|E707,128|
|B)<br>Analysis ofCash and Cash Equivalent|||||||
|Bank Current Accounts|||||1,695,520|1,275,034|
|Bank Deposit Accounts|||||950,000|950,000|
||||||2,645,520|E2,225,034|





## 



## 

## 

## 

## 

## 

## 



## 

## 

|||||2021||2020|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||Funds<br>f|Funds<br>f|Funds<br>f|Funds<br>f|
|2.|GRANTS AND DONATIONS||||||
||Donations<br>Grants||122,285|1,475,822|122,285<br>1,475,822|87,475<br>1,297,564|
||||f122,285|f1,475,822|f1,598,107|f1,385,039|
|3.|INVESTMENT INCOME||||||
||Bank interest||f159|f|f159|f3,381|
|4.|RESOURCES EXPENDED ON||||||
||CHARITABLE ACTIVITIES||||||
||Grants payable —Fellowship<br>Support costs (see note 5)|Payments|12,331<br>325,595|1,017,284|1,029,615<br>325,595|698,630<br>312317|
||||f337,926|f1,017,284|f1,355,210|f1,010,947|





## 

|||FOR THE YEAR ENDED 30TH NOVEMBER|FOR THE YEAR ENDED 30TH NOVEMBER|FOR THE YEAR ENDED 30TH NOVEMBER|2021|||
|---|---|---|---|---|---|---|---|
||||(Continued)|||||
|||||||2021|2020|
||||Unrestricted|Restricted||Total|Total|
||||Funds|Funds||Funds|Funds|
||||E|f||f|f|
|5.|SUPPORT COSTS|||||||
||Administrative<br>support||252,278|||252,278|245,498|
||Rent, light and heat||20,000|||20,000|20,000|
||Bank charges||266|||266|302|
||Telephone||2,144|||2,144|991|
||Printing,<br>postage and stationery||3,744|||3,744|4,631|
||Depreciation||1,347|||1,347|1,031|
||Insurance||1,524|||1,524|1,520|
||Legal and professional fees||5,550|||5,550|4,123|
||Trust development||6,492|||6,492|11,889|
||Meetings<br>and expenses||6,626|||6,626|6,129|
||Subscriptions<br>and publicity||1,962|||1,962|1,725|
||Website costs||666|||666|1,098|
||Staff training||4,899|||4,899|608|
||Sundry expenditure||3,759|||3,759|3,896|
||Daphne Jackson Trust Conference|||||||
||Auditors'<br>remuneration|—Audit|6,864|||6,864|6,600|
||Trustees and Committee|||||||
||Members costs||7,474|||7,474|2,276|
||||E325,595|E|—|E325,595|f312,317|
|6.|NET INCOME|||||||
||IS STATED AFTER CHARGING|||||||
||Auditors'<br>remuneration|—Audit|6,864|||6,864|6,600|
||Depreciation||1,347|||1,347|1,031|





## 

|to the charity amount|ed<br>to E|76,344 (20|20:f75,216).||||||
|---|---|---|---|---|---|---|---|---|
||||2021|||2020|||
||||Total Funds|||Total Funds|||
||||f|||E|||
|Gross wages<br>Employer's<br>national<br>Pension contributions|insurance|costs|231,232<br>14,397<br>6,649|||224,931<br>13,852<br>6,715|||
||||f252,278|||f245,498|||
|||||2021|||2020||
|The average number|ofemployees,||No.||FTE|No.||FTE|
|analysed<br>by function|was:||||||||
|Administration<br>ofcharitable||activities|12||7|12||7|



## 

## 

## 

|one o  <br><br> <br>were reimbursed<br>expenses totalling|<br> f256 (20|20:E1,086) during th|e period under revie|w.|
|---|---|---|---|---|
|FIXED ASSETS||Computer<br>Equipment<br>E|Office<br>Equipment<br>f|Totalf|
|Cost<br>At 1st December 2020<br>Additions||13,937<br>999|1,735|15,672<br>999|
|At 30th November 2021||14,936|1,735|16,671|
|Accumulated<br>Depreciation<br>At 1st December 2020<br>Charge for the year||11,972<br>1.312|1,595<br>35|13,567<br>1,347|
|At 30th November 2021||13,284|1,630|14,914|
|Net book value at 30th November|2021|E1,652|f105|E1,757|
|Net book value at 30th November|2020|E1,965|E140|E2,105|





## 

## 

||||2021|2020|
|---|---|---|---|---|
||||Total Funds|Total Funds|
||||f|f|
|11.|DEBTORS||||
||Debtors —Amounts|due from Sponsors|329,672|247,803|
||Other debtors||3,045||
||Prepayments||15,442|4,376|
||||f348,159|f252,179|
|12.|CREDITORS||||
||Trade creditors||143,112|144,745|
||Grants payable —Fellowships||269,695|146,663|
||Accruals||10,634|6,600|
||Deferred income||723,274|642,020|
||Other taxes and social security||||
||Other creditors||149,413|83,038|
||||f1,296,128|f1,023,066|







## 

## 

## 

||2021|||Total funds<br>brought<br>forward|Total<br>Income|Total<br>Expenditure|Transfers<br>between<br>funds||Total funds<br>carried<br>forward|
|---|---|---|---|---|---|---|---|---|---|
||Restricted funds<br>Grants payable to|||1,004,922|1,475,822|(1,017,284)|(351,823)||1,111,637|
||Fellows|||||||||
||Unrestricted<br>General fund|funds||451,330|122,444|(337,926)|351,823||587,671|
||Total funds|||E1,456,252|E1,598,266|f(1,355,210)|E|—|f1,699,308|
||2020|||Total funds<br>brought<br>forward|Total<br>Income|Total<br>Expenditure|Transfers<br>between<br>funds||Total funds<br>carried<br>forward|
||||||E|E|E||E|
||Restricted funds<br>Grants payable to|||748,977|1,297,564|(695,062)|(346,557)||1,004,922|
||Fellows|||||||||
||Unrestricted<br>General fund||funds|329,802|90,856|(315,885)|346557||451,330|
||Total funds|||E1,078,779|E1,388,420|E(1,010,947)|E|-|E1,456,252|
||Restricted funds are held in order to fund Fellowships.|||||||||
|17.|ANALYSIS OF||TRANSFERS BETWEEN FUNDS||Unrestricted<br>Restricted||||Total|
||||||Funds||Funds||E|
|||||||E|E|||
||Fellowship|Support Costs transferred|||351,823<br>(351,823)|||||
||||||E351,823<br>E(351,823)|||||



